Scott M. Lippman, M.D.: Short CV

More documents

Recommendations

Info

$Week 05\G, A and R 02.pdf$

Curriculum Vitae Scott M. Lippman, M.D. Page 34 3. Lippman SM, Lee JJ, Karp DD, Vokes EE, Benner SE, Goodman GE, Kardinal C, Winn RJ, Roth JA, Hong WK. Phase-III intergroup trial of 13-cis-retinoic acid to prevent second primary tumors in stage-I non-small cell lung cancer (NSCLC): Interim Report of NCI # I91-0001. Proc Am Soc Clin Oncol 17:456a (1753), 1998. 4. Shin DM, Lippman SM, Lee JJ, Hsu HA, Khuri FR, El-Naggar A, Lee JS, Hong WK, Hittelman WN. Genomic instability and long-term outcome in oral premalignant lesions (OPLs) following retinoid treatment. Proc Am Soc Clin Oncol 17:384a (1481), 1998. 5. Garden A, Glisson B, Ang K, Morrison W, Clayman G, Lippman S, Geara F, Shin DM, Khuri F, Goepfert H, Hong W, Peters L. Phase II trial of conventionally fractionated high dose radiation with concomitant boost chemotherapy for advanced head and neck squamous cell cancer (HNSCC). Proc Am Soc Clin Oncol 17:380a (1466), 1998. 6. Geyer C, Papadimitrakopoulou V, Lee JS, Lippman S, Xu XC, Lee J, Hong WK, Lotan R. A lack of association among the basal level of retinoic acid receptor β (RARβ) mRNA in oral premalignant lesions (OPLs), its upregulation by 13-cisretinoic acid (13cRA) and cancer development during a long-term follow-up. Proc Am Soc Clin Oncol 17:391a (1506), 1998. 7. Papadimitrakopoulou V, Khuri FR, Lippman SM, Shin DM, Ginsberg L, Glisson BS, Martinez L, Loewen G, Truglia J, Hong WK. Phase I/II evaluation of targretin (LGD1069), a novel, RXR-specific retinoid, in patients with recurrent squamous cell carcinoma of the head and neck. Proc Am Soc Clin Oncol 17:392a (1512), 1998. 8. Clifford JL, Wang M, Jain S, Lotan R, Lippman SM. Effect of the vitamin D analog (MC1288), all-trans retinoic acid, and interferon α2a on cutaneous squamous cell carcinoma cells. Proc Am Assoc Cancer Res 39:104 (706), 1998. 9. Salas T, Herrmann JL, McCrea PD, Lippman SM, Menter DG. Cadherin-catenin complexes as potential targets for chemoprevention. Proc Am Assoc Cancer Res 39:115 (782), 1998. 10. Boiko I, Lippman SM, Sneige N, Sahin A, Weber D, Risin S, Boone CW, Mitchell MF, Hittelman WN. Objective quantitation of nuclear grade in breast DCIS lesions by image analysis. Proc Am Assoc Cancer Res 39:116 (791), 1998. 11. Sun S-Y, Li W, Yue P, Lippman SM, Hong WK, Lotan R. The induction of apoptosis by 4-(N-hydroxyphenyl)retinamide (4HPR) in human cancer cells can be mediated by different mechanisms. Proc Am Assoc Cancer Res 39:358 (2443), 1998. 12. Clifford JL, Menter D, Wang M, Lotan R, Lippman SM. Retinoid receptordependent and independent effects of fenretinide. Proc Am Assoc Cancer Res 39:358 (2444), 1998. 13. Zou CP, Zou CC, Lippman SM, Lotan R. Identification of synthetic retinoids that are potent inducers of apoptosis in bladder cancer cells. Proc Am Assoc Cancer Res 39:359 (2449), 1998.
Curriculum Vitae Scott M. Lippman, M.D. Page 35 14. Shin DM, Lee JJ, Lippman SM, Hsu HA, El-Naggar A, Lee JS, Hong WK, Hittelman WN. High chromosome polysomy and p53 expression in persistent oral premalignant lesions (OPLs) following cessation of tobacco exposure. Proc Am Assoc Cancer Res 39:359 (2452), 1998. 15. Mao L, Fan YH, Shin DM, Papadimitrakopoulou V, El-Naggar AK, Izzo GJ, Lee JS, Clayman G, Shin JH, Hittelman WN, Lippman SM, Hong WK. Loss of heterozygosity (LOH) at 9p21 is frequent in head and neck preneoplastic lesions (HNPLs) and independent of clinical parameters. Proc Am Assoc Cancer Res 39:360 (2453), 1998. 16. Wei Q, Cheng L, Wang L, Guo Z, Strom SS, Spitz MR, Lippman SM, Duvic M, Kripke ML. Role of DNA repair for UV damage in non-melanoma skin cancer progression. Proc Am Assoc Cancer Res 39:477 (3245), 1998. 17. Hoque A, Atkinson N, Boiko I, Sneige N, Sahin A, Sabichi AL, Weber D, Lagios M, Schwarting R, Colburn W, Dhingra K, Kelloff G, Silverstein M, Boone C, Lippman SM, Hittelman WA. Recurrence in ductal carcinoma in situ (DCIS) of the breast and morphologic predictive image analysis features (PIAFS). Breast Cancer Res Treat 50:251 (161), 1998. 18. Zhang W, Wu H, Qiu H, Lippman SM, Lotan R, Xu X-C. Differential expression of nuclear retinoic acid receptor-β in normal, premalignant and malignant human esophageal tissues. Proc Am Assoc Cancer Res 40:432 (2854), 1999. 19. Li M, Lotan R, Lippman SM, Xu X-C. Induction of apoptosis of human esophageal cancer cells by aspirin. Proc Am Assoc Cancer Res 40:626 (4129), 1999. 20. Liu X-M, Zhang X-K, Lippman SM, Lotan R, Xu X-C. Stable transfection of retinoic acid receptor-β sense and anti-sense into esophageal cancer cells results in inverse modulation of growth and differentiation. Proc Am Assoc Cancer Res 40:535 (3529), 1999. 21. Mao L, Lippman SM, Fan YH, El-Naggar AK, Lee JJ, Liu D, Lee JS, Khuri F, Martin J, Hittelman WN, Hong WK. Loss of heterozygosity (LOH) at critical chromosomal loci as clonal marker in chemoprevention trial of oral premalignancies (OPMs). Proc Am Assoc Cancer Res 40:625 (4123), 1999. 22. Boiko IV, Hoque A, Sneige N, Atkinson N, Sahin A, Sabichi AL, Weber D, Lagios M, Schwarting R, Colburn W, Dhingra K, Kelloff G, Silverstein M, Boone C, Lippman SM, Hittelman WN. Image analysis as predictive factor for recurrence of ductal carcinoma in situ. Proc Am Assoc Cancer Res 40:431 (2847), 1999. 23. Hoque A, Lippman SM, Atkinson N, Boiko I, Sneige N, Sahin A, Sabichi AL, Weber D, Lagios M, Schwarting R, Colburn W, Dhingra K, Kelloff G, Silverstein M, Boone C, Hittelman WN. Predicting recurrent ductal carcinoma in situ (DCIS) of the breast: nuclear image analysis feature. Proc Am Assoc Cancer Res 40:431 (2846), 1999. 24. Clifford J, Sabichi AL, Lerner SP, Grossman HB, Zou CC, Caraway NP, Perez CA, Atkinson N, Levy L, Lippman SM. Assessment of apoptosis in bladder
Page 1 and 2: NAME: Scott M. Lippman, M.D. CURRIC
Page 3 and 4: Curriculum Vitae Scott M. Lippman,
Page 33: Curriculum Vitae Scott M. Lippman,

Scott M. Lippman, M.D.: Short CV

Create successful ePaper yourself

Delete template?

Save as template?